Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptomrecurrence after conservative surgery for endometriosis
|
|
- Asher Kennedy
- 6 years ago
- Views:
Transcription
1 Human Reproduction, Vol.24, No.11 pp , 2009 Advanced Access publication on July 22, 2009 doi: /humrep/dep259 ORIGINAL ARTICLE Gynaecology Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptomrecurrence after conservative surgery for endometriosis R. Seracchioli 1, M. Mabrouk, L. Manuzzi, C. Vicenzi, C. Frascà, A. Elmakky, and S. Venturoli Minimally Invasive Gynaecological Surgery Unit, Reproductive Medicine Unit, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy 1 Correspondance address. Tel: þ ; Fax: þ , seracchioli@aosp.bo.it background: Endometriosis recurrence after conservative surgery is not infrequent. Variable regimens of hormonal therapy have been proposed as adjuvant post-operative measures for prophylaxis against recurrence. Among these, the combined oral contraceptive pills (OCP), represents a valuable option in terms of safety and tolerability for long-term use. The objective of this review is to evaluate the effect of post-operative use of OCP in preventing symptom recurrence, and/or anatomical relapse of endometriosis. methods: A systematic search of Medline identified seven studies evaluating post-operative OCP treatment on prevention of endometriosis recurrence. results: A reduction in anatomical relapse rate was observed when oral contraceptive therapy was administered for more than 1 year after conservative surgery. Post-operative use of OCP was associated with a reduction in frequency and intensity of dysmenorrhoea recurrence. No association was found between OCP therapy and dyspareunia prevention, although the effect of OCP on chronic pelvic pain was conflicting. conclusion: Long-term OCP therapy can be a reliable adjuvant post-operative measure to prevent or reduce frequency/severity of recurrent dysmenorrhoea and anatomical relapse of endometriosis. Since both continuous and cyclic OCP administration regimens seem to have comparable effects, the choice of regimen can be modulated according to patient preferences. The protective effect seems to be related to the duration of treatment. Key words: endometrioma / pain / dysmenorrhoea / dyspareunia / chronic pelvic pain Introduction Endometriosis is a chronic gynaecological condition that affects women of reproductive age, causing infertility and pelvic pain. The pain may occur during menstrual bleeding (dysmenorrhoea), during sexual intercourse (dyspareunia) or not following any cyclical pattern (chronic pelvic pain) (Fauconnier and Chapron, 2005). If endometriosis involves the rectum or the bladder, symptoms as dyschezia or dysuria may respectively occur (Child and Tan, 2001; Milingos et al., 2003). Women affected by symptomatic endometriosis often report a significant reduction in their quality of life (Jones et al., 2004). Among the different endometriotic pelvic implants, ovarian endometrioma is the most common, affecting around 55% of patients (Liu et al., 2007). Excisional surgery is the treatment of choice, as it significantly reduces painful symptoms and improve quality of life in 67 80% of patients (Abbott et al., 2004). A frustrating aspect of conservative surgery, however, is the recurrence of endometriotic implants and painful symptoms at a long-term follow-up. It has been observed a cumulative rate of endometrioma recurrence of 12 30% after 2 5 years of follow-up (Busacca et al., 1999; Jones and Sutton, 2000; Chapron et al., 2002; Fedele et al., 2006; Guo, 2009). Recurrence & The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 2730 Figure 1 Flow-chart representing studies selection for the inclusion in the review. or worsening of pain has been observed in 7 30% of patients within 3 years of surgery, increasing to 40 50% after 5 years (Valle and Sciarra, 2003). Therefore, over recent years there has been particular interest in adjunctive post-operative hormonal therapy that reduces recurrence of endometriosis. As endometriotic tissue is hormonally sensitive, hormonal therapies could be effective in post-operative management of endometriosis (Child and Tan, 2001). It must be stressed, however, that hormones are not curative and endometriosis usually relapses at treatment suspension; therapies need therefore to be administered for long time. Oral contraceptives may be the best hormonal pharmacological choice, as they are safe, well tolerated, relatively inexpensive and can be administered for long periods (, 2008a). Oral contraceptive pills (OCP), both in cyclic and continuous regimen, have been used for years in clinical practice as adjuvant post-operative measure, even without a high-level evidence of their effectiveness (Rice, 2002; Rodgers and Falcone 2008). This review aims to evaluate the post-operative use of oral contraceptive therapy, both in cyclic and continuous administration, in preventing endometriosis recurrence. Materials and Methods Literature search criteria We performed a systematic search of Medline using the relevant medical subject heading search (MESH) with the following key words: endometriosis, pelvic pain, dysmenorrhoea, dyspareunia, endometrioma, OCP, postoperative treatment, recurrence. The studies were selected first by reading the title and the abstract and then independently screened by three authors who, after reading the full articles, selected the studies appropriate for the review. After discussion, there was a full consensus about the studies to be included in the review. The references of each selected study were also checked for other potential relevant studies. Studies evaluating OCP therapy, both in cyclic and continuous regimen, after conservative surgery for endometriosis were included in this review. Prevention or reduction of endometriosis recurrence was considered as outcome. Studies assessing anatomical and/or pain recurrence were included. Randomized controlled trials (RCTs), clinical trials (CTs), cohort and retrospective studies were included. Studies in which other hormonal therapies than oral contraceptives were administered before starting OCP therapy were excluded (Fig. 1). A validate scale (Jadad et al., 1996), evaluating randomization, double blinding and description of withdrawals or dropouts, was chosen to assess the quality of the retrieved RCTs. Results Description of the studies Seven studies that evaluated the effects of post-operative OCP on prevention of endometriosis recurrence were considered for this review. Details of the studies are summarized in Table I. Three studies assessed anatomical recurrence (Koga et al., 2006;, 2008), three focused on pain recurrence (Vercellini et al., 2003; Sesti et al., 2007;, 2009) and one considered both (Muzii et al., 2000). Among these studies, four evaluated the effect of a long-term OCP therapy (, 2003, 2008b;, 2008, 2009). Six studies were prospective trials: four were RCTs (Muzii et al., 2000; Sesti et al., 2007;, 2008, 2009), one was a self-controlled CT (, 2003) and one was a cohort study (, 2008b). One study was retrospective (Koga et al., 2006). Among RCTs, three trials (Muzii et al., 2000;, 2008, 2009) compared OCP therapy with no post-operative treatment and
3 OCP in prophylaxis of endometriosis recurrence 2731 Table I Design of the studies considered Study Outcome Type of study Number of patients Medical Treatment... Muzii et al. (2000) Anatomical and pain recurrence RCT 35 None 33 Cyclic OCP (2003) Pain recurrence Prospective self controlled 50 Continuous OCP Koga et al. (2006) Anatomical recurrence Retrospective 109 none 15 OCP Sesti et al. (2007) Pain recurrence RCT 110 placebo 38/39 Continuous OCP/GnRH-analogues 35 Dietary therapy (2008a, b) Anatomical recurrence Cohort study 46 None 231 Cyclic OCP (2008) Anatomical recurrence RCT 69 None 75 Cyclic OCP 73 Continuous OCP (2009) Pain recurrence RCT 87 None 92 Cyclic OCP 95 Continuous OCP RCT: randomized controlled trial; OCP: oral contraceptive pills. one (Sesti et al., 2007) analysed pain recurrence comparing the effects of hormonal therapy (OCP and GnRH-analogues), dietary therapy and placebo. The quality score of RCTs assessed by the Jadad s scale was 3/5 for all the four included studies, since an appropriate double blinding was not performed in any of the studies considered (Jadad et al., 1996). (2003) assessed the efficacy of continuous OCP administration in pain relief in women whom post-operative prophylaxis with cyclic OCP failed to prevent dysmenorrhea recurrence. The same group of authors compared the risk of endometrioma recurrence among patients who used OCP for the entire follow-up period (28 months), those who used the same therapy discontinuously (stopped therapy before 28 months) and patients who did not receive any treatment from the beginning (, 2008b). Koga et al., in their retrospective study, evaluated the independent effect of 14 variables on ovarian endometrioma recurrence after conservative surgery. One of the evaluated variables was post-operative medical therapy, including GnRH-agonist, danazol and oral contraceptives (Koga et al., 2006). Surgery performed and stage of endometriosis All the studies included patients who underwent conservative surgery for endometriosis. Laparoscopy and laparotomy for symptomatic disease were both considered in the studies of (2003; endometriosis stages I IV) and Sesti et al. (2007; endometriosis stages III IV). The remaining studies (Muzii et al.,2000; Koga et al., 2006;, 2008, 2009;, 2008b), focused on women who underwent laparoscopic of ovarian endometriosis. Medical and surgical interventions are summarized in Table II. Type of pills and regimen A low-dose monophasic oral contraceptive therapy was administered in all the considered studies. Regimens: (i) cyclic regimen was used in two studies; ethinyl estradiol (EE) mg, gestodene (Muzii et al., 2000) and EE mg, desogestrel 0.15 mg (, 2008b). (ii) continuous regimen was used in two studies; EE mg, desogestrel 0.15 mg (, 2003) and EE mg, gestodene (Sesti et al., 2007). (iii) cyclic and continuous administrations of OCP (EE mg, gestodene ) were both evaluated in Seracchioli s trials (, 2008, 2009). Koga et al. (2006) did not specify the regimen nor the composition of the oral contraceptive administered in their study. Time of therapy and follow-up The duration of therapy and follow-up differed among the selected studies (Table II). A 6 month treatment regimen was evaluated in two studies (Muzii et al., 2000; Sesti et al., 2007); the follow-up was for 22 (range 12 48) and 12 months, respectively. In one study (Koga et al., 2006) the mean duration of post-operative therapy was 9.5 months and patients were followed up for at least 24 months. Four studies evaluated the effect of a long-term OCP therapy (, 2003;, 2008, 2009;, 2008b). Among these three (, 2003;, 2008, 2009) assessed 24-months OCP administration and follow-up. In the final study (, 2008b) the mean follow-up was of 28 months, although the length of treatment varied depending on women preferences: patients who did not withdrew the therapy took OCP for the entire follow-up period. Criteria for outcome evaluation and definition of recurrence Outcomes measured and definition of recurrence in the considered studies are summarized in Table III.
4 2732 Table II Surgical and medical interventions performed in the studies considered Study Surgical treatment OCP Type of pill Time of medical treatment Follow-up Regimen (months) (months)... Muzii et al. (2000) Cyclic EE mg, gestodene 6 22 (2003) Koga et al. (2006) LPS or LPT Continuous EE mg, desogestrel 0.15 mg Sesti et al. (2007) LPS or LPT Continuous EE mg, gestodene (2008a, b) (2008) (2009) LPS: laparoscopy; LPT: laparotomy; EE: ethinilestradiol Not specified Not specified Cyclic Cyclic Continuous Cyclic Continuous EE mg, desogestrel 0.15 mg EE mg, gestodene EE mg, gestodene In all the studies evaluating anatomical recurrence (Muzii et al., 2000; Koga et al., 2006;, 2008;, 2008b), it was defined as new appearance of endometriotic ovarian cyst, diagnosed by the detection of a cyst with all typical aspects by transvaginal ultrasonography (Exacoustos et al., 2003). In two studies (Koga et al., 2006;, 2008b) a diagnostic cut-off in cyst diameter of 2 cm was used, although (2008) considered cysts with a minimum diameter of 1.5 cm, and one study (Muzii et al., 2000) did not specify any cut-off in cyst diameter. Studies that considered painful symptoms (Muzii et al., 2000;, 2003; Sesti et al., 2007;, 2009), graded their intensity by a visual analogue scale (VAS) (Huskisson, 1983); (2003) also used a 0- to 3- point verbal rating scale (VRS). Two trials (Muzii et al., 2000;, 2009) defined pain recurrence as severity of pain graded 4 on a 10-point VAS; Muzii et al. considered pelvic pain, although evaluated dysmenorrhoea, dyspareunia and chronic pelvic pain separately. (2003) evaluated dysmenorrhoea improvement, comparing VAS and VRS scores during previous cyclic OC use and after 24 months of continuous OC use. Sesti et al. (2007) evaluated dysmenorrhoea, dyspareunia and chronic pelvic pain comparing VAS scores of the different groups. Results of the studies Results of the selected studies are described on the basis of the evaluated outcomes and duration of the administered therapy. Anatomical recurrence Short-term therapy In the trial of Muzii, the difference in endometrioma recurrence rate between patients receiving OCP (2.9%) and untreated patients (6.1%) was not significant. In life-table analysis, a lower rate of recurrence of endometrioma was observed at 12 months in the treated group whereas no significant differences were detected at 24 and 36 months (Muzii et al., 2000). Koga et al. (2006) found that post-operative medical therapy does not significantly influence longterm recurrence rate of endometrioma. Long-term therapy (2008b) observed that, at 36 months follow-up, crude recurrence rate was 9% in the group of patients treated by postoperative OCP for the entire follow-up period and 56% in the untreated group [P, 0.001; odds ratio (OR) 0.07]. Logistic regression showed that only OCP use was associated with a significant modification of the risk of recurrence. The adjusted OR for OCP use was Furthermore, the analysis of endometrioma recurrence rate in women who used OCP discontinuously demonstrated a gradient effect with regard to duration of treatment (P, 0.001), suggesting that the protective effect of estro-progestinic therapy tends to rapidly diminish after withdrawal. (2008), at 24 months follow-up, observed an endometrioma crude recurrence rate of 29% in untreated patients versus 14.7 and 8.2% in women treated with OCP in cyclic and continuous administration, respectively. A significant difference in recurrence rate was observed between untreated patients versus women treated with OCP (P, 0.005). Furthermore, the mean diameter of endometriomas at the first observation and the increase of cysts dimensions were significantly reduced in women treated with OCP (P, 0.005) suggesting that therapy can reduce disease severity and restrain its progression. No significant differences were detected between cyclic and continuous OCP administration. New appearance of deep infiltrating endometriosis was not described in any of the studies considered. Symptoms recurrence Short-term therapy In the trial of Muzii, no significant difference in the recurrence rates of pain was observed at follow-up between patients receiving OCP
5 OCP in prophylaxis of endometriosis recurrence 2733 Table III Results of the studies Study Outcome Method of Definition of Patients and Results P-value measured measurement recurrence treatment... Muzii et al. Endometrioma TV US Not specified 35 no therapy Recurrence rate: ocp (2.9%) versus NS (2000) none (6.1%) pain VAS VAS cyclic OCP Recurrence rate: ocp (9.1%) versus NS none (17.1%) (2003) Koga et al. (2006) Sesti et al. (2007) (2008a, b) (2008) (2009) Dysmenorrhoea VAS, VRS Not specified 50 continuous OCP Reduction in mean VAS score of 45.95% after 2 years of continuous OCP therapy,0.001 Endometrioma TV US.2 cm diameter 109 no therapy OCP do not influence endometrioma NS 15 OCP recurrence (a) Dysmenorrhoea VAS Not specified 110 placebo (a) Lower VAS scores with OCP,,0.001 GnRH-analogues and dietary therapy (b) Dyspareunia 77 hormonal (b) Lower VAS scores with placebo,0.001 therapy (c) CPP 35 dietary therapy (c) Lower VAS scores with OCP,,0.001 GnRH-analogues and dietary therapy Endometrioma TV US.2 cm diameter 46 no therapy Recurrence rate: ocp (9%) versus none, cyclic OCP (56%) Endometrioma TV US.1.5 cm diameter 69 no therapy Recurrence rate: ocp continuous (8.2%), cyclic OCP and cyclic OCP (14.7%) versus none 73 continuous (29%) OCP (a) Dysmenorrhoea VAS VAS.4 87 no therapy (a) Lower recurrence rate since 6,0.001 months (continuous OCP) or 18 months (cyclic OCP) (b) Dyspareunia 92 cyclic OCP (b) OCP do not influence recurrence NS (c) CPP 95 continuous OCP (c) OCP do not influence recurrence NS CPP: chronic pelvic pain; TV US: transvaginal ultrasonography; VAS: visual analogue scale; VRS: verbal rating scale; OCP: oral contraceptive pill, NS: non-significant. (9.1%) and untreated patients (17.1%). As for the anatomical recurrence, in life-table analysis a lower rate of recurrence of symptoms was observed at 12 months in the treated group whereas no significant differences were detected at 24 and 36 months (Muzii et al., 2000). Sesti et al. observed, at 12 months follow-up, a lower VAS score for dysmenorrhoea and chronic pelvic pain in the patients treated with OCP, GnRH-analogues or dietary therapy respect to patients in the control group (P, 0.001). The placebo, otherwise, was more effective than hormonal or dietary therapy in decreasing dyspareunia intensity (P, 0.001) (Sesti et al., 2007). Long-term therapy (2009) observed a significant reduction in frequency and severity of recurrent dysmenorrhoea in patients receiving 24 months OCP therapy compared with surgery alone. Benefits of oral contraceptives were evident since the first follow-up visit, at 6 months, for the patients in continuous treatment, and after 18 months of follow-up in the women treated in cyclic regimen (P, ). No significant differences in terms of frequency and severity of dyspareunia and chronic pelvic pain were found among patients treated with OCP, both cyclic and continuous, and patients in the control group. Untreated patients, however, showed a significant worsening in dysmenorrhoea, dyspareunia and chronic pelvic pain intensity from 6 to 24 months of follow-up compared with patients in continuous OCP therapy (P, 0.001). (2003) reported a mean reduction in VAS score of 45.95% after 2 years of continuous OCP therapy (P, 0.001), showing that long-term continuous OCP can be successfully used in women with endometriosis-associated recurrent dysmenorrhoea that does not respond to cyclic OCP use after surgical treatment. Discussion Several OCP mechanisms of action can justify oral contraceptives use in the prevention of endometriosis recurrence, both anatomical and symptomatic. Oral contraceptives reduce menstrual flow and retrograde menstruation and can therefore prevent the reseeding of refluxed endometrial tissue (Busacca, 2006). Furthermore, the inhibition of ovulation induced by OCP may reduce the risk of endometrioma development; since some authors hypothesized that endometriotic cysts might develop from ovarian follicles (Jain and Dalton, 1999). It has also been demonstrated that OCP can induce atrophy of the endometriotic implants (Rodgers and Falcone, 2008), can down-regulate cell proliferation and increase apoptosis in endometrial tissue (Meresman et al., 2002). Therefore OCP therapy might prevent implant growth and reduce endometriosis-related pain, since the pain seems correlated to the cyclic micro-bleeding
6 2734 within the endometriotic lesions (Fauconnier and Chapron, 2005). In addition, OCP reduce the production of prostaglandins, involved in pain genesis, and can reduce the inflammatory status (Crosignani et al., 2006;, 2008a). All these mechanisms suggest that OCP can be effective in preventing endometriosis recurrence. From the analysis of the studies considered in this review, it seems that there is a growing body of evidence supporting OCP use as a reliable adjuvant post-operative measure, effective in the reduction of endometriosis recurrence. However, two of the studies included here (Koga et al., 2006; Muzii et al., 2000) report findings that contradict this statement; neither observed an association between post-operative use of OCP and longterm reduction of disease recurrence. In these studies, however, the duration of treatment should be taken into account, as it could have been responsible for the lack of long-term effects. Koga et al. retrospectively evaluated a hormonal treatment of 9.5 months and suggested that an administration longer than 1 year may be effective in preventing endometriosis recurrence. Muzii et al. reported, after a 6 months administration of OCP, a reduction in endometriosis recurrence at 12 months of follow-up. The lack of long-term effects, therefore, could be due to discontinuation of therapy more than to a real inefficacy of post-operative oral contraceptives. This hypothesis has been confirmed by the study of (2008b), who demonstrated a protective effect of OCP on current but not on previous users, showing a strong correlation between the duration of the treatment and the long-term effects. Post-operative OCP treatment, therefore, needs to be administered for years rather than months to successfully prevent endometriosis recurrence. Regarding recurrence of endometriosis-related symptoms, not all the types of pain considered seem to be equally responsive to postoperative OCP. Dysmenorrhoea, the symptom most frequently reported by women with endometriosis, can be successfully controlled by oral contraceptives. Continuous OCP can provide early reduction of dysmenorrhoea after 6 months of treatment (Sesti et al., 2007;, 2009), although cyclic OCP need to be administered for at least 18 months to be effective (Seracchioli et al., 2009). Furthermore continuous administration is a valuable treatment option for dysmenorrhoea that does not respond to cyclic use of OCP (, 2003). It is possible that the capacity of continuous OCP in preventing or reducing dysmenorrhoea could be due to inhibition of menses, rather than to a real interference with pain mechanisms. Also noteworthy is that the induced amenorrhoea could be unacceptable to some patients, mainly young women who would need to prolong therapy for years. Long-term cyclic administration may therefore be a reliable treatment option for those women who do not tolerate the absence of menstruation. Cyclic use of low-dose OCP, however, may not be sufficient to induce a complete ovarian suppression, allowing the increase of endogenous estrogens levels during the 7-days hormone-free interval (Sulak, 2008). Recently, a new regimen of OCP administration, consisting in 24 days of active combined therapy followed by 4 days of suspension (24 þ 4 regimen), has been proposed for contraception (Sulak, 2008). Theoretically, reduction in menstrual bleeding achieved with this new regimen could be effective in the prevention of endometriosis recurrence. However, further studies are necessary to assess the role of the 24 þ 4 regimen in the management of endometriosis. Only two studies in this review (Sesti et al., 2007;, 2009) evaluated endometriosis-related dyspareunia and chronic pelvic pain. Regarding dyspareunia, there is no evidence of a positive effect of post-operative OCP (Sesti et al., 2007;, 2009). Furthermore, Sesti et al. demonstrated that placebo seems to be more effective than hormonal therapy in relieving this type of pain. They explained this finding by the fact that dyspareunia perception may be influenced by psychological factors depending on woman personality, marital and psychosexual issues (Sesti et al., 2007). Regarding chronic pelvic pain, there is no agreement about the effects of post-operative OCP. (2009) did not find differences between patients treated with OCP and untreated patients in terms of chronic pelvic pain recurrence, although Sesti et al. (2007) found significant differences in favour of post-operative OCP use. The more evident benefits achieved with oral contraceptives on dysmenorrhoea in comparison with dyspareunia and chronic pelvic pain can be explained by the fact that dysmenorrhoea can be related to endometrial bleeding, that can be decreased or suppressed by OCP, although other types of pain are possibly due to different physiopathologic mechanisms. Higher concentration of activated immune cells, such as mast cell and macrophages, growth factors such as nerve growth factor, and pro-inflammatory cytokines have been observed in peritoneal fluid of women with endometriosis (Evans et al., 2007). All these factors have been shown to contribute to persistent pain (Moalem and Tracey, 2006). Some authors suggested that this inflammatory status could activate, sensitize and/or increase nociceptors present in endometrium and peritoneum (Evans et al., 2007). Furthermore, deep endometriotic implants can compress or infiltrate the subperitoneal nerves (Anaf et al., 2006), suggesting a neuropathic component in pain related to endometriosis (Evans et al., 2007). Although efficacy of OCP in prevention of dyspareunia and chronic pelvic pain has not yet been clearly defined, (2009) showed that oral contraceptives are effective in restraining aggravation of dysmenorrhoea, dyspareunia and chronic pelvic pain. Furthermore, OCP therapy can reduce dimensions and growth of recurrent endometriomas, suggesting their role in restraining disease progression (, 2008). In conclusion, long-term administration of OCP seems to be a valuable adjuvant post-operative measure in women undergoing conservative surgery for symptomatic endometriosis. Since both continuous and cyclic administrations seem similarly effective in reducing endometriosis recurrence, the choice of the regimen can be modulated according to patient preferences. Further statistically-powered RCTs, with a long-term therapy and a long follow-up period, would better provide recommendations regarding the OCP administration regimen and the specific combinations used. References Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic of endometriosis: a randomized, placebo-controlled trial. Fertil Steril 2004;82: Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noël JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006;86: Busacca M. Pain and endometriosis: an overview. J Minim Invasive Gynecol 2006;13:
7 OCP in prophylaxis of endometriosis recurrence 2735 Busacca M, Marana R, Caruana P, Candiani M, Muzii L, Calia C, Bianchi S. Recurrence of ovarian endometrioma after laparoscopic. Am J Obstet Gynecol 1999;180: Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB. Management of ovarian endometriomas. Hum Reprod Update 2002;8: Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treatment. Drugs 2001;61: Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update 2006;12: Evans S, Moalem-Taylor G, Tracey DJ. Pain and endometriosis. Pain 2007; 132:S22 S25; Review. Exacoustos C, Zupi E, Carusotti C, Rinaldo D, Marconi D, Lanzi G, Arduini D. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 2003;10: Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005; 11: Fedele L, Bianchi S, Zanconato G, Berlanda N, Raffaelli R, Fontana E. Laparoscopic of recurrent endometriomas: long-term outcome and comparison with primary surgery. Fertil Steril 2006; 85: Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009; [Epub ahead of print]. Huskisson EE. Visual analogue scales. Pain Measurement and Assessment. New York: Raven Press, 1983, Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1 12. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril 1999; 72: Jones KD, Sutton CJ. Laparoscopic management of ovarian endometriomas: a critical review of current practice. Curr Opin Obstet Gynecol 2000;12: ; Review. Jones G, Jenkinson C, Kennedy S. The impact of endometriosis upon quality of life: a qualitative analysis. J Psychosom Obstet Gynaecol 2004; 25: Koga K, Takemura Y, Osuga Y, Yoshino O, Hirota Y, Hirata T, Morimoto C, Harada M, Yano T, Taketani Y. Recurrence of ovarian endometrioma after laparoscopic. Hum Reprod 2006; 21: Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol 2007;109: Milingos S, Protopapas A, Drakakis P, Liapi A, Loutradis D, Kallipolitis G, Milingos D, Michalas S. Laparoscopic management of patients with endometriosis and chronic pelvic pain. Ann N Y Acad Sci 2003; 997: Meresman GF, Augè L, Baranao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002;77: Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;5: ; Review. Muzii L, Marana R, Caruana P, Catalano GF, Margutti F, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Am J Obstet Gynecol 2000;183: Rice VM. Conventional medical therapies for endometriosis. Ann N Y Acad Sci 2002;955: ; discussion , , Review. Rodgers AK, Falcone T. Treatment strategies for endometriosis. Expert Opin Pharmacother 2008;9: Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Montanari G, Keramyda A, Venturoli S. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril 2008; [Epub ahead of print]. Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Savelli L, Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic of ovarian endometriosis: a randomized controlled trial. Fertil Steril 2009; [Epub ahead of print]. Sesti F, Pietropolli A, Capozzolo T, Broccoli P, Pierangeli S, Bollea MR, Piccione E. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III IV. A randomized comparative trial. Fertil Steril 2007;88: Sulak PJ. Continuous oral contraception: changing times. Best Pract Res Clin Obstet Gynaecol 2008;22: Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci 2003;997: Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasini R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80: Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008a;22: Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008b;198:504.e1 504.e5. Submitted on February 26, 2009; resubmitted on June 23, 2009; accepted on June 25, 2009
Chapter 3. Renato Seracchioli Mohamed Mabrouk Clarissa Frascà Linda Manuzzi Luca Savelli Stefano Venturoli Fertil Steril Jul; 94(2):
Chapter 3 Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial Renato Seracchioli Mohamed Mabrouk Clarissa
More informationRenato Seracchioli, M.D., Mohamed Mabrouk, M.D., Clarissa Frasca, M.D., Linda Manuzzi, M.D., Luca Savelli, M.D., and Stefano Venturoli, M.D.
Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial Renato Seracchioli, M.D., Mohamed Mabrouk, M.D.,
More informationLong-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial Renato Seracchioli, M.D., Mohamed Mabrouk, M.D., Clarissa Frasca, M.D., Linda Manuzzi,
More informationAnalysis of risk factors for the removal of normal ovarian tissue during laparoscopic cystectomy for ovarian endometriosis
Human Reproduction, Vol.24, No.6 pp. 1402 1406, 2009 Advanced Access publication on February 26, 2009 doi:10.1093/humrep/dep043 ORIGINAL ARTICLE Gynaecology Analysis of risk factors for the removal of
More informationPre and post surgical medical therapy. Mauro Busacca M.D. Dept of Obstetrics and Gynecology University of Milan- Italy
Pre and post surgical medical therapy Mauro Busacca M.D. Dept of Obstetrics and Gynecology University of Milan- Italy introduction A disease is an open problem when two conditions are nor satisfied: The
More informationLow-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial
ENDOMETRIOSIS Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial Tasuku Harada, M.D., a Mikio Momoeda, M.D., b Yuji Taketani,
More informationLaparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery
Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery Luigi Fedele, M.D., a Stefano Bianchi, M.D., a Giovanni Zanconato, M.D., c Nicola Berlanda, M.D.,
More informationDiagnostic accuracy and potential limitations of transvaginal sonography for bladder endometriosis
Ultrasound Obstet Gynecol 2009; 34: 595 600 Published online 14 October 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7356 Diagnostic accuracy and potential limitations of transvaginal
More informationLaparoscopy and Endometriosis: Preventing Complications and Improving Outcomes. Luis C. Paez M.D.
Laparoscopy and Endometriosis: Preventing Complications and Improving Outcomes Luis C. Paez M.D. Assumptions Pelvic pain Not desiring immediate fertility H & P suggest endometriosis OC/NSAID failures Endo
More informationCritical Appraisal of Endometriosis Management for Pain and Subfertility
Critical Appraisal of Endometriosis Management for Pain and Subfertility N. F. Zuberi,J. H. Rizvi ( Department of Obstetrics and Gynaecology, The Aga Khan University, Karachi. ) Introduction Endometriosis
More informationDienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis
doi:10.1111/jog.13023 J. Obstet. Gynaecol. Res. Vol. 42, No. 9: 1152 1158, September 2016 Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis Yotaro
More informationSurgical treatment of endometriosis: location and patterns of disease at reoperation
Surgical treatment of endometriosis: location and patterns of disease at reoperation Elizabeth Taylor, M.D., and Christina Williams, M.D. Division of Reproductive Endocrinology and Infertility, Department
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationA multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of
A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group
More informationKey Message. Introduction AOGS MAIN RESEARCH ARTICLE
A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis:
More informationSurgical treatment of deep endometriosis and risk of recurrence
Journal of Minimally Invasive Gynecology (2005) 12, 508-513 Surgical treatment of deep endometriosis and risk of recurrence Michele Vignali, MD, Stefano Bianchi, MD, Massimo Candiani, MD, Giovanna Spadaccini,
More informationEndometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax
Endometriosis What you need to know 139 Dumaresq Street Campbelltown Phone 4628 5292 Fax 4628 0349 www.nureva.com.au September 2015 What is Endometriosis? Endometriosis is a condition whereby the lining
More informationMANAGEMENT OF REFRACTORY ENDOMETRIOSIS
(339) MANAGEMENT OF REFRACTORY ENDOMETRIOSIS Serdar Bulun, MD JJ Sciarra Professor and Chair Department of Ob/Gyn Northwestern University ENDOMETRIOSIS OCs Teenager: severe dysmenorrhea often starting
More informationSurgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
Page: 1 of 7 Last Review Status/Date: June 2015 for Primary and Secondary Dysmenorrhea Description Two laparoscopic surgical approaches are proposed as adjuncts to conservative surgical therapy for the
More informationSurgical Management of Endometriosis associated Infertility
Surgical Management of Endometriosis associated Infertility Dr. Ingrid Lok Specialist in Obstetrics and Gynaecology (Honorary Clinical Associate Professor, CUHK) HA commission training 24.2.2014 Endometriosis
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationA prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas
FERTILITY AND STERILITY VOL. 82, NO. 6, DECEMBER 2004 Copyright 2004 American Society for Reproductive Medicine ublished by Elsevier Inc. rinted on acid-free paper in U.S.A. A prospective, randomized study
More informationSurgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea Policy Number: 4.01.17 Last Review: 11/2013 Origination: 11/2007 Next Review: 11/2014 Policy Blue Cross and Blue Shield
More informationSurgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea. Original Policy Date
MP 4.01.10 Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date
More informationClinica Ostetrica e Ginecologica I, Istituto Luigi Mangiagalli, University of Milano, Milan, Italy
FERTILITY AND STERILITY VOL. 80, NO. 2, AUGUST 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Comparison of a levonorgestrel-releasing
More informationOriginal Article. Abstract
Original Article Frequency of endometriosis among infertile women and association of clinical signs and symptoms with the Laparoscopic staging of Endometriosis Urooj Bakht Khawaja, 1 Ameer Ali Khawaja,
More informationPostoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence A randomized controlled study
Accepted Manuscript Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence A randomized controlled study Yi-Jen Chen, M.D., Ph.D., Teh-Fu Hsu, M.D., Ben-Shian
More informationEndometriosis an Enigma- Review Article
Volume 2 Issue 1 2018 Page 212 to 217 Editorial Gynaecology and Perinatology ISSN: 2576-8301 Endometriosis an Enigma- Review Article Dr. Sreelatha S 1 *, Dr. Shruthi A 2, Dr. Vandana Ambastha 2, Dr. Asha
More informationA Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis
SH SUEN & SCS CHAN A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis Sik Hung SUEN MBChB, MRCOG Resident
More informationEndometriosis. *Chocolate cyst in the ovary
Endometriosis What is endometriosis? Endometriosis is a common condition in young women. It's chronic, painful, and it often progressively gets worse over the time. *Chocolate cyst in the ovary Normally,
More informationPRESACRAL NEURECTOMY AND UTERINE NERVE ABLATION FOR PELVIC PAIN
PRESACRAL NEURECTOMY AND UTERINE NERVE ABLATION FOR PELVIC PAIN Protocol: PAI008 Effective Date: November 1, 2015 Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 DESCRIPTION
More informationCNGOF Guidelines for the Management of Endometriosis
CNGOF Guidelines for the Management of Endometriosis Anatomoclinical forms of endometriosis Definitions Endometriosis is defined as the presence of endometrial tissue containing both glands and stroma
More informationInvestigations and management of severe endometriosis
Investigations and management of severe endometriosis Dr Jim Tsaltas Head of Gynaecological Endoscopy and Endometriosis Surgery Monash Health Monash University Dept of O&G Melbourne IVF Freemasons Hospital
More informationDiagnostic value of transvaginal tenderness-guided ultrasonography for the prediction of location of deep endometriosis
Human Reproduction Vol.23, No.11 pp. 2452 2457, 2008 Advance Access publication on July 29, 2008 doi:10.1093/humrep/den293 Diagnostic value of transvaginal tenderness-guided ultrasonography for the prediction
More informationMoneli Golara Consultant Obstetrician and Gynaecologist Barnet Hospital Royal Free NHS Trust
Moneli Golara Consultant Obstetrician and Gynaecologist Barnet Hospital Royal Free NHS Trust Endometriosis one of the most common conditions requiring treatment Growth of endometrial like tissue outside
More informationIs the endometriosis recurrence rate increased after ovarian hyperstimulation?
Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Thomas M. D Hooghe, M.D., Ph.D., Bénédicte Denys, M.D., Carl Spiessens, Ph.D., Christel Meuleman, M.D., and Sophie Debrock,
More informationEndometriosis: Correlation of Severity of Pain with Stages of Disease
Journal of Bangladesh College of Physicians and Surgeons Vol. 34, No. 3, July 2016 Endometriosis: Correlation of Severity of Pain with Stages of Disease TS CHOWDHURY a, N MAHMUD b, TA CHOWDHURY c Summary:
More informationEffect of Surgical Removal of Endometriomas on Cyclic and Non-cyclic Pelvic Pain
Original Article Effect of Surgical Removal of Endometriomas on Cyclic and Non-cyclic Pelvic Pain Murat Api, M.D., Ph.D., Aysen Telce Boza, M.D.*, Semra Kayatas, M.D., Mustafa Eroglu, M.D. Zeynep Kamil
More informationEndometriosis of the ureter and bladder are not associated diseases
ENDOMETRIOSIS Endometriosis of the ureter and bladder are not associated diseases Mauricio Simoes Abrao, M.D., Ph.D., a,b Joao Antonio Dias, Jr, M.D., a,b Patrick Bellelis, M.D., a Sergio Podgaec, M.D.,
More informationPalm Beach Obstetrics & Gynecology, PA
Palm Beach Obstetrics & Gynecology, PA 4671 S. Congress Avenue, Lake Worth, FL 33461 561.434.0111 4631 N. Congress Avenue, Suite 102, West Palm Beach, FL 33407 Endometriosis The lining of the uterus is
More informationIs painful rectovaginal endometriosis an intermediate stage of rectal endometriosis?
Is painful rectovaginal endometriosis an intermediate stage of rectal endometriosis? Horace Roman, M.D., a Alexis Gromez, M.D., a Patrick Hochain, M.D., b Nolwenn Marouteau-Pasquier, M.D., c Jean-Jacques
More informationNorethisterone acetate in the treatment of colorectal endometriosis: a pilot study
Human Reproduction, Vol.25, No.1 pp. 94 100, 2010 Advanced Access publication on October 10, 2009 doi:10.1093/humrep/dep361 ORIGINAL ARTICLE Gynaecology Norethisterone acetate in the treatment of colorectal
More informationunderstanding endometriosis Authored by Dr KT Subrayen Sponsored by
understanding endometriosis Authored by Dr KT Subrayen Sponsored by in this booklet What is Endometriosis? 1 What causes Endometriosis? 3 What does Endometriosis look like? 4 Common symptoms of Endometriosis
More informationMedical Management of Endometriosis: Novel Targets and Future Treatments Erkut Attar, M.D. PhD.
Medical Management of Endometriosis: Novel Targets and Future Treatments Erkut Attar, M.D. PhD. Istanbul University Istanbul Medical School Department of Obstetrics & Gynecology Division of Reproductive
More informationEndometriosis. Assoc.Prof.Pawin Puapornpong, Faculty of Medicine, Srinakharinwirot University.
Endometriosis Assoc.Prof.Pawin Puapornpong, Faculty of Medicine, Srinakharinwirot University. Endometriosis Definition: Ectopic Endometrial Tissue True Incidence Unknown:? 1-5% Does NOT Discriminate by
More informationDifference Between PCOS and Endometriosis
Difference Between PCOS and Endometriosis www.differencebetween.com Key Difference PCOS vs Endometriosis Ovaries play an important role in the reproduction and the maintenance of the female body. They
More informationImpact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles
1 st SEUD Meeting, 9 May 2015, Paris, France Impact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles ENDOMETRIOSIS ovarian endometrioma
More informationPRESACRAL NEURECTOMY AND UTERINE NERVE ABLATION FOR PELVIC PAIN
MEDICAL POLICY PRESACRAL NEURECTOMY AND UTERINE NERVE ABLATION FOR PELVIC PAIN Policy Number: 2014T0059K Effective Date: October 1, 2014 Table of Contents BENEFIT CONSIDERATIONS COVERAGE RATIONALE APPLICABLE
More informationPROLIFERATIVE ACTIVITIES OF ECTOPICAL ENDOMETRIAL CELLS IN PATIENTS WITH PRIMARY AND RECURRENT ENDOMETRIOMAS
Federal State Institute «Rostov-on-Don Scientific Research Institute of Obstetrics and Pediatrics», Rostov State Medical University PROLIFERATIVE ACTIVITIES OF ECTOPICAL ENDOMETRIAL CELLS IN PATIENTS WITH
More informationCY Tse, AMK Chow, SCS Chan. Introduction
Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study CY Tse, AMK Chow, SCS Chan Objective. To evaluate
More informationPublic Statement: Medical Policy Statement: Background:
ARBenefits Approval: 10/12/2011 Effective Date: 01/01/2012 Revision Date: Code(s): 58578, unlisted laparoscopy procedure, uterus Medical Policy Title: Surgical Interruption of Pelvic Nerve Pathways for
More informationDeep infiltrating endometriosis is frequent in all stages of endometriosis and the depth of infiltration influences surgical parameters proportionally
Journal of Endometriosis 2; 2 ( 4) : 25-22 ORIGINAL ARTICLE Deep infiltrating endometriosis is frequent in all stages of endometriosis and the depth of infiltration influences surgical parameters proportionally
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationEndometriosis and Infertility - FAQs
Published on: 8 Apr 2013 Endometriosis and Infertility - FAQs Introduction The inner lining of the uterus is called the endometrium and it responds to changes that take place during a woman's monthly menstrual
More informationORILISSA (elagolix) oral tablet
ORILISSA (elagolix) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationVaporization of ovarian endometrioma using plasma energy: histologic findings of a pilot study
Vaporization of ovarian endometrioma using plasma energy: histologic findings of a pilot study In ten ovarian endometriomas of diameter exceeding 30 mm, managed by complete vaporization of the inner surface
More informationPharmacological treatment of endometriosis: update from recent clinical trials
Review: Clinical Trial Outcomes Pharmacological treatment of endometriosis: update from recent clinical trials Clin. Invest. (2011) 1(1), 109 117 Endometriosis is a chronic disease that causes pain and
More informationCigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Pelvic Denervation Procedures Table of Contents Coverage Policy... 1 General Background... 1 Coding/Billing Information... 4 References... 4 Effective Date... 6/15/2014
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationBy: Dr. Safoura Rouholamin
By: Dr. Safoura Rouholamin Introduction Endometriosis as an enigmatic disease is most commonly found on the ovaries and presents with pelvic pain and infertility. laparoscopic stripping has been introduced
More informationSmita Jain, M.B., M.S.* and Maureen E. Dalton, F.R.C.O.G. Sunderland Royal Hospital, Sunderland, Tyne and Wear, United Kingdom
ENDOMETRIOSIS FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Chocolate
More informationPelvic Denervation Procedures
Medical Coverage Policy Pelvic Denervation Procedures Effective Date...06/15/2018 Next Review Date...06/15/2019 Coverage Policy Number... 0368 Table of Contents Coverage Policy... 1 Overview... 1 General
More informationExcisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review
Human Reproduction Vol.20, No.11 pp. 3000 3007, 2005 doi:10.1093/humrep/dei207 Excisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review Roger Hart 1,3, Martha Hickey 1,
More informationDefinition Endometriosis is the presence of functioning endometrial tissue outside the cavity of the uterus.
Dept. of Obstetrics t and Gynecology Faculty of Medicine University of Sumatera Utara Endometriosis Definition Endometriosis is the presence of functioning endometrial tissue outside the cavity of the
More informationInt J Clin Exp Med 2013;6(7): /ISSN: /IJCEM Yi Han 1,2, Shi-En Zou 1, Qi-Qi Long 1, Shao-Fen Zhang 1
Int J Clin Exp Med 2013;6(7):583-588 www.ijcem.com /ISSN:1940-5901/IJCEM1306010 Original Article The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined
More informationDownloaded from Bilateral fetal head size endometriomas with deep infiltrating endometriosis in an adolescent girl.
Submitted on: May 2015 Accepted on: June 2015 For Correspondence Email ID: Medrech ISSN No. 2394-3971 BILATERAL FETAL HEAD SIZE ENDOMETRIOMAS WITH DEEP INFILTRATING ENDOMETRIOSIS IN AN ADOLESCENT GIRL
More informationCancer arising from Endometriosis and Its Clinical implications
Cancer arising from Endometriosis and Its Clinical implications 1) Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign
More informationManaging infertility when adenomyosis and endometriosis co-exist
Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China Endometriosis Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects
More informationFDG-PET value in deep endometriosis
Gynecol Surg (2011) 8:305 309 DOI 10.1007/s10397-010-0652-6 ORIGINAL ARTICLE FDG-PET value in deep endometriosis A. Setubal & S. Maia & C. Lowenthal & Z. Sidiropoulou Received: 3 December 2010 / Accepted:
More informationConservative approach to rectosigmoid endometriosis: a cohort study
AOGS ORIGINAL RESEARCH ARTICLE Conservative approach to rectosigmoid endometriosis: a cohort study ANNE G. EGEKVIST 1,2, EDVARD MARINOVSKIJ 3, AXEL FORMAN 1,2, ULRIK S. KESMODEL 4,5, MADS RIISKJÆR 1,2
More informationDoes Helica treatment of early endometriosis confer short- and long-term benefits in terms of pain relief and sub-fertility?
Gynecol Surg (2013) 10:213 217 DOI 10.1007/s10397-013-0803-7 ORIGINAL ARTICLE Does Helica treatment of early endometriosis confer short- and long-term benefits in terms of pain relief and sub-fertility?
More informationTheFormationofaScoringSystemtoDiagnoseEndometriosis. The Formation of a Scoring System to Diagnose Endometriosis
Global Journal of Medical Research: E Gynecology and Obstetrics Volume 18 Issue 1 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 49-4618
More informationThe pharmacological management of ENDOMETRIOSIS
The pharmacological management of ENDOMETRIOSIS 18 Endometriosis is a gynaecological condition in which endometrial tissue is present outside the uterine cavity, causing cyclic symptoms and, often, reduced
More informationSurgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation
Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation Martin Healey, M.D., W. Catarina Ang, M.B., B.S., and Claudia Cheng, M.B., B.S. Royal
More informationEndometriosis Information Leaflet
Endometriosis Information Leaflet What is Endometriosis? Endometriosis is a condition where tissue similar to the lining of the womb (endometrium) is found outside the womb. About 1 out of 10 women of
More information1 2 Infertile women are seven to ten times more likely to have endometriosis than their fertile 3 The mechanism by which endometriosis develops is unknown Theories for the histogenesis of endometriosis
More informationNEW TREATMENTS FOR OVARIAN ENDOMETRIOMA
SEUD 2018 NEW TREATMENTS FOR OVARIAN ENDOMETRIOMA Ivo Brosens Giuseppe Benagiano Faculty of Medicine, KU Leuven, Belgium Sapienza University, Rome, Italy Hughesdon P.E. (1957) THE OVARIAN ENDOMETRIOMA
More information2/24/19. Myometrial evaluation. Size Echotexture. Homogeneous Heterogeneous. Adenomyosis Fibroids. Adenomyosis. MUSA guidelines
Content Adenomyosis and MUSA guidelines for myometrial disorders Adenomyosis MUSA guidelines Dr Lufee Wong FRANZCOG, MPH, DDU Recommended reporting guidelines Fibroids Adenomyosis Myometrial evaluation
More informationintractable dysmenorrhea are diagnosed with endometriosis. 5
Endometriosis From Identification to Management Endometriosis, a gynecologic disorder that typically affects women of childbearing age, can result in dysmenorrhea, deep dyspareunia, chronic pelvic pain,
More informationENDOMETRIOSIS When and how to implement treatment
ENDOMETRIOSIS When and how to implement treatment Francisco Carmona Hospital Clínic ENDOMETRIOSIS TREATMENT It depends on the severity of symptoms the patient's desire for pregnancy the extent of disease
More informationThe effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis
Gynecological Endocrinology, March 2008; 24(3): 123 128 ENDOMETRIOSIS The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis HUGO MAIA JR 1,
More informationEndometriosis: Unveiling the contemporary issues in diagnosis and treatment
Annals of Health Research Volume 4, Issue No 1: 1-6 January-June 2018 DOI: 10.30442/ahr.0401-1-01 ORIGINAL RESEARCH Endometriosis: Unveiling the contemporary issues in diagnosis and treatment Fabamwo AO*,
More informationENDOMETRIOSIS. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis
FERTILITY AND STERILITY VOL. 77, NO. 6, JUNE 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ENDOMETRIOSIS Oral contraceptives
More informationThe biology of menstrually related. Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives REPORTS. Patricia J.
REPORTS Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives Patricia J. Sulak, MD Abstract Managing premenstrual symptoms at the most fundamental level necessitates careful consideration
More informationSaint Mary s Hospital. Gynaecology Unit. Saint Mary s Hospital. Endometriosis. Information For Patients
Saint Mary s Hospital Gynaecology Unit Saint Mary s Hospital Endometriosis Information For Patients Contents What is endometriosis?... 3 What happens?... 3 Who is affected?... 3 Outlook... 3 What are the
More informationMenstrual Discomfort L O O K, F E E L A N D L I V E B E T T E R
Menstrual Discomfort LOOK, FEEL AND LIVE BET TER Pycnogenol for Menstrual Discomfort Most women of child-bearing age experience a variety of symptoms related to the menstrual cycle that may be limited
More informationInt J Clin Exp Med 2016;9(10): /ISSN: /IJCEM
Int J Clin Exp Med 2016;9(10):19935-19943 www.ijcem.com /ISSN:1940-5901/IJCEM0027833 Original Article Clinical outcome of various regimens of gonadotropin-releasing hormone analogues after conservative
More informationEffectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data
Original Article Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data Reproductive Sciences 1-8 ª The Author(s) 2018 Reprints and permission: sagepub.com/journalspermissions.nav
More informationSurgical management of peritoneal endometriosis. GKS koulutuspäivät Jaana Fraser PKSSK
Surgical management of peritoneal endometriosis GKS koulutuspäivät 24.9.2009 Jaana Fraser PKSSK Peritoneal endometriosis Tumor-like small lesions, located on the surface of peritoneum Diameter some millimeters
More informationREPRODUCTIVE SURGERY. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial MATERIALS AND METHODS
REPRODUCTIVE SURGERY FERTILITY AND STERILITY VOL. 82, NO. 4, OCTOBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Laparoscopic
More informationImpact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference
A C TA Obstetricia et Gynecologica MAIN RESEARCH ARTICLE Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference MARIA ELISABETTA COCCIA
More informationWhat s New in Adolescent Contraception?
What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationSurgery of symptomatic DIE is required
Laparoscopic treatment of deeply infiltrating endometriosis i ESRHE 27/11/2009 Leuven M Nisolle, J Dequesne, C Innocenti, JM Foidart University of Liège,Belgium Deep infiltrating endometriosis Rectovaginal
More informationWHAT IS ENDOMETRIOSIS?
WHAT IS ENDOMETRIOSIS? Endometriosis is a common and sometimes debilitating condition affecting 7-10% of women of any nationality and has no cure. It is an estrogen dependent disease, so affects women
More informationEndometriosis: diagnosis and management
National Institute for Health and Care Excellence Version 3.0 Endometriosis: diagnosis and management Appendices D, F and H - J NICE guideline Review protocol, identified studies, excluded studies, forest
More informationTreatment of ovarian endometrial cysts in the context of recurrence and fertility
Reviews Treatment of ovarian endometrial cysts in the context of recurrence and fertility *Izabela Nowak-Psiorz A D,F, *Sylwester M. Ciećwież A D,F, Agnieszka Brodowska A,B,D,F, Andrzej Starczewski A,B,D,F
More informationPregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study
ORIGINAL RESEARCH KERALA MEDICAL JOURNAL Pregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study Anupama R KJK Hospital, Nalanchira,
More informationEndometriosis Treatment & Management Medscape
Endometriosis Treatment & Management Medscape Updated: Apr 25, 2016 Author: G Willy Davila, MD; Chief Editor: Michel E Rivlin, MD more... Approach Considerations The dependence of endometriosis on the
More informationDiagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study
Human Reproduction, Vol.24, No.12 pp. 3019 3024, 2009 Advanced Access publication on August 18, 2009 doi:10.1093/humrep/dep275 ORIGINAL ARTICLE Gynaecology Diagnosis of endometriosis by detection of nerve
More information